Aclaris Therapeutics ACRS Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's tax on share settlement?
- Aclaris Therapeutics (ACRS) reported tax on share settlement of $250K in Q1 2026.
- How has Aclaris Therapeutics's tax on share settlement changed year-over-year?
- Aclaris Therapeutics's tax on share settlement decreased by 9.1% year-over-year, from $275K to $250K.
- What is the long-term trend for Aclaris Therapeutics's tax on share settlement?
- Over 4 years (2021 to 2025), Aclaris Therapeutics's tax on share settlement has grown at a -38.5% compound annual growth rate (CAGR), from $3.12M to $446K.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.